Qa

Are secondaries too good to be true?

Cyril Demaria, head of private markets at Wellershoff & Partners, argues secondaries provide a false sense of security to investors and that the benefits of mitigating the J-curve may have been oversold to LPs.

SL Capital: five questions with Patrick Knechtli

The fund of funds unit of Standard Life Investments closed its third secondaries fund in October. Secondaries Investor speaks to its head of secondaries about the fundraise, investor expectations and negotiating a ‘lumpy’ market.

Challenges and opportunities in European direct secondaries

Cipio Partners’ Roland Dennert discusses the kind of deals he is seeing, the problem with unicorns and how a maturing tech industry is likely to mean larger funds in future.

What returns on agri secondaries?

Sister publication Agri Investor spoke to Stafford Capital Partners’ Bernd Schanzenbaecher to find out more about the firm’s agriculture strategy days after it made its first investment in the asset class.

Landmark’s 2017 predictions

Ian Charles, a partner on Landmark Partners’ private equity team and Jamie Sunday, a partner on the firm’s real estate team, discuss the market’s challenges and their predictions for the rest of 2017

Industry Ventures’ Swildens on VC secondaries

Hans Swildens is chief executive and founder of the venture capital-focused fund of funds and secondaries specialist. He speaks to Secondaries Investor about who’s selling what, the rise of corporate spin-outs, and how small and complex rules the day.

Landmark on the return of the mega-deal, part 1

Ian Charles, a partner on Landmark Partners’ private equity team and Jamie Sunday, a partner on the firm’s real estate team, discuss how secondaries transactions worth more than $1bn may lead to a record year for deal volume.

Evercore’s Dawn on rolling over assets, part 1

Nigel Dawn, from advisor Evercore, discusses some of the ways in which GPs can strategically access the secondaries market to actively manage their portfolios, as well as LPs’ familiarity with asset sales.

Proskauer on tail-ends and preferred equity

Proskauer’s Kate Simpson and Mike Suppappola discuss important legal and structural ramifications that have arisen amid increased diversification in deal types.

Q&A: Rudy Scarpa and Matt Jones from Pantheon

Pantheon’s global private equity secondaries team is changing: London-based Matt Jones and New York-based Rudy Scarpa will take over from Elly Livingstone, who will dedicate more time to fundraising and dealmaking. The two of them talk to Secondaries Investor.